What is NDC 85477-330?

85477-330 is the product NDC for Lidexa, Lidocaine 38.8 mg/g cream, listed with the FDA by Oncora Pharma, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.

Oncora Pharma, LLC, NDC labeler code 85477. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Lidexa?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Lidexa NDC 85477-330 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)85477-330Labeler and product segments. Claims need a package NDC.

Product NDC at billing width85477-0330Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
85477-330-07	8547703300785477033007	85 g in 1 BOTTLE, PUMP (85477-330-07)Marketed from Feb 26, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Lidexa
Generic name (nonproprietary): lidexa
Active ingredients: Lidocaine — 38.8 mg/g
Dosage form: Cream
Route: Topical
Labeler: Oncora Pharma, LLCNDC labeler code 85477
Product type: Prescription drug
Marketing category: Unapproved drug (other)
Marketing start: Feb 26, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Amides (Chemical structure)Local Anesthesia (Physiologic effect)
Identifiers: Product ID 85477-330_cb6c85bc-f245-431d-8ded-4a4d8c83dbb2SPL ID cb6c85bc-f245-431d-8ded-4a4d8c83dbb2SPL set ID 46d6b3b8-3a9a-44c2-b807-a32f24945f4aRxCUI 1723991UNII 98PI200987UPC 0854770330078
Pharmacologic class: Amide Local Anesthetic; Antiarrhythmic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N485477033007 followed by a unit qualifier and the quantity

Package 85477-0330-07. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 27, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Lidexa™ is indicated for topical analgesia as directed by a healthcare provider.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 85477-330

What is NDC 85477-330?: 85477-330 is the product NDC for Lidexa, Lidocaine 38.8 mg/g cream, listed with the FDA by Oncora Pharma, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Lidexa.
What is the active ingredient?: Lidocaine.
Who is the labeler?: Oncora Pharma, LLC, NDC labeler code 85477. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Lidexa?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.